Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific nTPM	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific nTPM	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific nTPM	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific nTPM	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific nTPM	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific nTPM	RNA tissue cell type enrichment	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific nTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific nTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Blood expression cluster	Tissue expression cluster	Cell line expression cluster	Single cell expression cluster	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	RNAsingleCellTypeSpecific
NDUFS1	CI-75k	ENSG00000023228	NADH:ubiquinone oxidoreductase core subunit S1	P28331	2	206114817-206159509	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins	Electron transport, Respiratory chain, Transport	Oxidoreductase, Translocase	Disease variant, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 181.7;skeletal muscle: 221.6;tongue: 225.2	Cell type enriched	Detected in all	6	Cardiomyocytes: 845.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA064605, CAB070844	Enhanced		Supported	Mitochondria					48000	Cluster 14: Monocytes - Unknown function	Cluster 8: Non-specific - Mitochondria	Cluster 45: Non-specific - Cell proliferation	Cluster 77: Cardiomyocytes - Muscle contraction	Mitochondria		CAB070844: , HPA064605: AB_2685297	prognostic unfavorable (3.85e-4)	unprognostic (1.76e-1)	unprognostic (9.22e-3)	unprognostic (5.01e-2)	unprognostic (8.63e-3)	unprognostic (3.75e-1)	unprognostic (3.72e-2)	unprognostic (6.18e-2)	unprognostic (2.30e-2)	unprognostic (3.28e-1)	unprognostic (2.00e-2)	unprognostic (1.28e-1)	prognostic favorable (1.47e-12)	unprognostic (1.17e-1)	unprognostic (1.29e-1)	unprognostic (4.76e-2)	unprognostic (4.73e-2)	Cardiomyocytes
TIMM21	C18orf55, HSPC154, TIM21	ENSG00000075336	Translocase of inner mitochondrial membrane 21	Q9BVV7	18	74148523-74160531	Predicted membrane proteins	Protein transport, Translocation, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Cardiomyocytes: 246.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Heart muscle - Cardiomyocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010587, HPA051543	Uncertain									Cluster 27: Non-specific - Gene expression	Cluster 39: Non-specific - Mitochondria	Cluster 41: Non-specific - Cilium assembly	Cluster 77: Cardiomyocytes - Muscle contraction			HPA010587: AB_1851244, HPA051543: AB_2681528	unprognostic (4.88e-1)	unprognostic (2.20e-2)	unprognostic (1.16e-1)	unprognostic (8.61e-2)	unprognostic (3.81e-2)	unprognostic (3.19e-1)	prognostic unfavorable (9.22e-5)	unprognostic (1.42e-1)	unprognostic (1.59e-2)	unprognostic (1.93e-2)	unprognostic (4.79e-3)	unprognostic (1.55e-3)	prognostic favorable (1.38e-9)	unprognostic (2.37e-2)	unprognostic (5.39e-2)	unprognostic (1.31e-1)	unprognostic (6.66e-2)	Cardiomyocytes
NMRK2	ITGB1BP3, MIBP, NRK2	ENSG00000077009	Nicotinamide riboside kinase 2	Q9NPI5	19	3933103-3942416	Enzymes, Metabolic proteins, Predicted intracellular proteins	Pyridine nucleotide biosynthesis	Kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	116	heart muscle: 1438.4;skeletal muscle: 634.8;tongue: 722.1	Cell type enriched	Detected in some	10	Cardiomyocytes: 1153.8	Cancer enhanced	Detected in some		renal cancer: 32.8;testis cancer: 13.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	liver cancer: 2.8;skin cancer: 5.1;testis cancer: 6.2		Not detected	Not detected			Not detected	Not detected			HPA049909, HPA054792, HPA072450	Approved		Enhanced	Nucleoplasm,Vesicles							Cluster 38: Heart - Muscle contraction	Cluster 16: Skin cancer - Melanocyte processes	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoplasm	Vesicles	HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522				unprognostic (3.61e-1)	unprognostic (5.92e-2)	unprognostic (1.18e-2)		unprognostic (2.54e-1)	unprognostic (1.03e-1)	unprognostic (7.61e-2)		unprognostic (3.30e-2)	prognostic favorable (1.19e-4)	unprognostic (1.72e-1)	unprognostic (3.29e-2)	unprognostic (5.38e-1)		Cardiomyocytes
TBX5	HOS	ENSG00000089225	T-box transcription factor 5	Q99593	12	114353911-114408442	Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Atrial fibrillation, Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 88.1;lung: 20.8;placenta: 28.7	Cell type enriched	Detected in some	10	Cardiomyocytes: 111.4	Cancer enhanced	Detected in some		lung cancer: 1.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	9	Bone cancer: 4.0	Heart muscle - Cardiomyocytes, Prostate - Fibroblasts, Skin - Fibroblast_2	Not detected	Not detected			Low region specificity	Detected in single			HPA008786, HPA064683	Uncertain		Approved	Nucleoplasm							Cluster 44: Heart - Cardiac muscle contraction	Cluster 20: Connective tissue cells - ECM organization	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoplasm		HPA008786: AB_10601720, HPA064683: AB_2685320	unprognostic (3.09e-2)	unprognostic (1.53e-1)			unprognostic (3.79e-2)	unprognostic (2.75e-1)		unprognostic (1.62e-1)	unprognostic (1.42e-1)	unprognostic (1.66e-1)	unprognostic (1.09e-1)	unprognostic (8.67e-2)	unprognostic (3.36e-7)	unprognostic (2.29e-2)	unprognostic (1.68e-2)	unprognostic (7.34e-2)	unprognostic (4.38e-3)	Cardiomyocytes
MYH7	CMD1S, CMH1, MPD1	ENSG00000092054	Myosin heavy chain 7	P12883	14	23412740-23435660	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	71	heart muscle: 7569.2;skeletal muscle: 14554.3;tongue: 5378.8	Cell type enriched	Detected in some	31	Cardiomyocytes: 13557.3	Group enriched	Detected in some	9	head and neck cancer: 12.2;prostate cancer: 15.4	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in many							HPA001239, HPA001349, CAB015384	Enhanced		Uncertain	Focal adhesion sites					43000000		Cluster 13: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 77: Cardiomyocytes - Muscle contraction	Focal adhesion sites		CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437	unprognostic (6.49e-2)	unprognostic (8.27e-5)	unprognostic (1.56e-1)	unprognostic (3.04e-3)	unprognostic (4.30e-1)	unprognostic (7.33e-3)		unprognostic (8.60e-2)	unprognostic (1.55e-1)	unprognostic (1.31e-1)	unprognostic (1.22e-1)	unprognostic (3.79e-1)	unprognostic (5.38e-3)	unprognostic (2.32e-1)	unprognostic (1.20e-1)	unprognostic (1.41e-1)	unprognostic (2.28e-2)	Cardiomyocytes
MYL12A	MLCB, MRCL3, MRLC3, MYL2B	ENSG00000101608	Myosin light chain 12A	P19105	18	3247481-3256236	Predicted intracellular proteins		Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	heart muscle: 4234.5;skeletal muscle: 3072.7;tongue: 2082.4	Cell type enriched	Detected in all	4	Cardiomyocytes: 7352.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Skeletal muscle - Skeletal myocytes					Low region specificity	Detected in all			CAB004503, HPA039262, HPA045244, HPA059197	Supported						Yes			Cluster 44: Non-specific - Transcription	Cluster 38: Heart - Muscle contraction	Cluster 20: Connective tissue cells - ECM organization	Cluster 77: Cardiomyocytes - Muscle contraction			CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944	unprognostic (2.14e-3)	unprognostic (5.30e-2)	unprognostic (1.80e-1)	unprognostic (5.31e-2)	unprognostic (3.03e-2)	unprognostic (7.95e-2)	unprognostic (1.41e-1)	unprognostic (1.57e-3)	unprognostic (2.02e-1)	unprognostic (2.53e-2)	unprognostic (1.49e-3)	unprognostic (2.30e-1)	unprognostic (9.86e-2)	unprognostic (1.30e-1)	unprognostic (4.98e-2)	unprognostic (4.58e-3)	unprognostic (7.13e-2)	Cardiomyocytes
ZNF106	SH3BP3, ZFP106, ZNF474	ENSG00000103994	Zinc finger protein 106	Q9H2Y7	15	42412823-42491141	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 392.5;tongue: 465.5	Cell type enriched	Detected in all	5	Cardiomyocytes: 2425.7	Cancer enhanced	Detected in all		melanoma: 29.4	Low region specificity	Detected in all			Immune cell enhanced	Detected in all		neutrophil: 161.0	Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Adipose subcutaneous - Adipocytes (Subcutaneous), Breast - Adipocytes (Breast), Skin - Macrophages	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol						Cluster 1: Neutrophils - Mixed function	Cluster 13: Striated muscle - Muscle contraction	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoli	Nucleoplasm, Cytosol	HPA054267: AB_2682431	unprognostic (2.15e-2)	unprognostic (3.31e-1)	unprognostic (7.10e-2)	unprognostic (2.61e-2)	unprognostic (4.01e-2)	unprognostic (1.34e-1)	unprognostic (9.32e-2)	unprognostic (2.49e-1)	unprognostic (3.96e-1)	unprognostic (1.33e-2)	unprognostic (2.27e-1)	unprognostic (2.07e-1)	unprognostic (1.76e-3)	unprognostic (8.71e-2)	unprognostic (1.78e-1)	unprognostic (4.36e-1)	unprognostic (4.09e-3)	Cardiomyocytes
MYL7	MYL2A, MYLC2A	ENSG00000106631	Myosin light chain 7	Q01449	7	44138864-44141332	Predicted intracellular proteins		Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	1061	heart muscle: 23165.6	Cell type enriched	Detected in some	45	Cardiomyocytes: 8539.0	Cancer enriched	Detected in some	7	testis cancer: 3.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	testis cancer: 47.6;Uterine cancer: 12.5	Heart muscle - Cardiomyocytes	Not detected	Not detected							HPA013331, CAB033884, HPA039262	Enhanced										Cluster 44: Heart - Cardiac muscle contraction	Cluster 10: Ovarian & Endometrial cancers - Unknown function	Cluster 77: Cardiomyocytes - Muscle contraction			CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418	unprognostic (1.00e-2)	unprognostic (7.99e-2)		unprognostic (4.36e-3)	unprognostic (2.31e-1)	unprognostic (2.51e-1)				unprognostic (1.28e-1)	unprognostic (7.85e-2)				unprognostic (1.67e-1)		unprognostic (7.28e-2)	Cardiomyocytes
MYL2	CMH10	ENSG00000111245	Myosin light chain 2	P10916	12	110910819-110921443	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease variant, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	72	heart muscle: 27910.5;skeletal muscle: 28967.7;tongue: 19823.2	Cell type enriched	Detected in some	7	Cardiomyocytes: 26504.8	Group enriched	Detected in some	46	head and neck cancer: 31.5;prostate cancer: 25.5	Region enriched	Detected in some	6	hypothalamus: 6.0	Group enriched	Detected in some	12	memory B-cell: 1.1;naive B-cell: 1.2	Lineage enriched	Detected in single	12	B-cells: 1.2	Cancer enriched	Detected in some	12	Rhabdoid: 57.3	Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in some			HPA019763, HPA039262	Supported		Uncertain	Microtubules					180000	Cluster 19: B-cells - Humoral immune response	Cluster 38: Heart - Muscle contraction	Cluster 40: Non-specific - Enzymes	Cluster 77: Cardiomyocytes - Muscle contraction	Microtubules		HPA019763: AB_1854243, HPA039262: AB_2676418	unprognostic (2.07e-2)	unprognostic (1.37e-1)		unprognostic (1.39e-1)		prognostic unfavorable (2.60e-4)		unprognostic (1.32e-1)	unprognostic (4.05e-2)	unprognostic (4.82e-2)	unprognostic (2.05e-2)	unprognostic (2.20e-1)		unprognostic (1.76e-1)	unprognostic (2.84e-1)	unprognostic (3.55e-1)		Cardiomyocytes
MFN2	CMT2A2, CPRP1, KIAA0214, MARF	ENSG00000116688	Mitofusin 2	O95140	1	11980181-12015211	Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Apoptosis, Autophagy, Unfolded protein response	Hydrolase	Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 270.4;skeletal muscle: 310.5;tongue: 337.6	Cell type enriched	Detected in all	6	Cardiomyocytes: 404.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Colon - Smooth muscle cells, Prostate - Smooth muscle cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030554, CAB079902	Uncertain		Supported	Mitochondria						Cluster 8: Neutrophils - Inflammatory response	Cluster 8: Non-specific - Mitochondria	Cluster 38: Non-specific - mRNA processing	Cluster 77: Cardiomyocytes - Muscle contraction	Mitochondria		CAB079902: AB_2724683, HPA030554: AB_10603018	unprognostic (9.52e-2)	unprognostic (1.80e-1)	unprognostic (1.42e-1)	unprognostic (4.38e-2)	unprognostic (8.36e-2)	unprognostic (9.71e-2)	unprognostic (1.89e-1)	unprognostic (2.44e-1)	unprognostic (3.45e-1)	unprognostic (2.19e-2)	unprognostic (1.43e-1)	unprognostic (3.55e-1)	prognostic favorable (2.36e-8)	unprognostic (4.69e-2)	unprognostic (2.76e-1)	unprognostic (8.84e-3)	unprognostic (2.12e-1)	Cardiomyocytes
TNNT2	CMD1D, CMH2, CMPD2	ENSG00000118194	Troponin T2, cardiac type	P45379	1	201359008-201377764	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins		Muscle protein	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	205	heart muscle: 10670.6	Cell type enriched	Detected in some	56	Cardiomyocytes: 1054.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Sarcoma: 135.8;testis cancer: 61.2	Heart muscle - Cardiomyocytes, Kidney - Podocytes	Low region specificity	Detected in many			Region enhanced	Detected in some		cerebral cortex: 3.8	CAB015371, HPA015774, HPA017888	Enhanced		Uncertain	Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules		No	No		57000		Cluster 44: Heart - Cardiac muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoplasm, Nucleoli	Focal adhesion sites, Microtubules	CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355	unprognostic (1.45e-1)	unprognostic (2.74e-1)	unprognostic (2.33e-4)	unprognostic (1.85e-1)	unprognostic (7.29e-2)	unprognostic (1.79e-1)	unprognostic (1.80e-1)	unprognostic (1.24e-1)	unprognostic (1.42e-1)	unprognostic (2.91e-2)	unprognostic (1.38e-1)	unprognostic (8.63e-2)	unprognostic (5.50e-3)	unprognostic (2.94e-1)	unprognostic (1.61e-1)	unprognostic (4.76e-2)	unprognostic (9.98e-2)	Cardiomyocytes
GHRH	GHRF	ENSG00000118702	Growth hormone releasing hormone	P01286	20	37251086-37261814	Human disease related genes, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	brain: 199.5	Cell type enriched	Detected in single	10	Cardiomyocytes: 7.0	Cancer enriched	Detected in some	7	urothelial cancer: 8.5	Region enriched	Detected in some	12	hypothalamus: 199.5	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	33	lung cancer: 19.0		Region enriched	Detected in many	9	hypothalamus: 32.9	Region enhanced	Detected in some		hypothalamus: 3.7						Secreted in other tissues					Cluster 45: Eosinophils - Innate immune response	Cluster 73: Brain - Neuropeptide signaling	Cluster 41: Non-specific - Cilium assembly	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (4.78e-2)				unprognostic (2.57e-2)									unprognostic (1.58e-1)	unprognostic (3.10e-1)			Cardiomyocytes
CASQ2	PDIB2	ENSG00000118729	Calsequestrin 2	O14958	1	115700021-115768714	Disease related genes, Human disease related genes, Predicted intracellular proteins		Muscle protein	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	heart muscle: 1056.7	Cell type enriched	Detected in some	4	Cardiomyocytes: 978.5	Cancer enhanced	Detected in many		head and neck cancer: 5.1	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Sarcoma: 2.7	Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Breast - Endothelial cells, Colon - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Skin - Smooth muscle cells, Thyroid - Smooth muscle cells	Region enriched	Detected in all	6	cerebellum: 43.1	Low region specificity	Detected in all			HPA027285, HPA055298	Enhanced				Intracellular and membrane						Cluster 38: Heart - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 77: Cardiomyocytes - Muscle contraction			HPA027285: AB_1845933, HPA055298: AB_2682777	unprognostic (1.13e-1)	unprognostic (1.52e-1)	unprognostic (9.70e-3)	unprognostic (1.28e-1)	unprognostic (3.41e-2)	prognostic unfavorable (2.30e-4)	unprognostic (1.03e-4)	unprognostic (1.78e-1)	unprognostic (2.37e-1)	unprognostic (1.92e-1)	unprognostic (1.34e-1)	unprognostic (8.92e-2)	unprognostic (7.20e-3)	unprognostic (1.82e-2)	unprognostic (1.80e-1)	unprognostic (2.83e-1)	prognostic unfavorable (2.25e-5)	Cardiomyocytes
LDB3	CMD1C, KIAA0613, PDLIM6, ZASP	ENSG00000122367	LIM domain binding 3	O75112	10	86668507-86736072	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins			Cardiomyopathy, Disease variant, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	26	heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4	Cell type enriched	Detected in some	4	Cardiomyocytes: 2096.7	Group enriched	Detected in some	4	head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Thyroid - Smooth muscle cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA048955	Enhanced		Supported	Nucleoplasm,Focal adhesion sites,Cytosol					750000		Cluster 13: Striated muscle - Muscle contraction	Cluster 7: Neuronal cell lines - Stereocilium	Cluster 77: Cardiomyocytes - Muscle contraction	Focal adhesion sites, Cytosol	Nucleoplasm	HPA048955: AB_2680568	unprognostic (1.60e-1)	unprognostic (9.01e-2)	unprognostic (4.87e-2)	unprognostic (6.92e-2)	unprognostic (5.55e-2)	unprognostic (1.50e-2)	unprognostic (2.57e-2)	unprognostic (1.36e-1)	unprognostic (2.79e-2)	unprognostic (7.61e-2)	unprognostic (2.54e-3)	unprognostic (3.55e-2)	unprognostic (4.72e-4)	unprognostic (3.07e-2)	unprognostic (1.60e-1)	unprognostic (1.62e-2)	unprognostic (3.16e-1)	Cardiomyocytes
KLHL31	bA345L23.2, BKLHD6, KBTBD1	ENSG00000124743	Kelch like family member 31	Q9H511	6	53647916-53665756	Predicted intracellular proteins	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 51.3;skeletal muscle: 146.1;tongue: 34.8	Cell type enriched	Detected in some	8	Cardiomyocytes: 339.8	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in single			Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Not detected	Not detected														Cluster 13: Striated muscle - Muscle contraction	Cluster 61: Liver - Metabolism	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (7.27e-2)	unprognostic (6.18e-2)	unprognostic (2.31e-1)	unprognostic (1.10e-1)	unprognostic (1.67e-1)	unprognostic (7.67e-4)	unprognostic (2.23e-2)	unprognostic (1.25e-1)	unprognostic (2.55e-1)	unprognostic (3.98e-2)	unprognostic (5.50e-2)	unprognostic (4.24e-1)	unprognostic (1.09e-4)	unprognostic (8.73e-2)	unprognostic (2.88e-1)	unprognostic (1.23e-1)	unprognostic (1.40e-1)	Cardiomyocytes
TNNI3	CMD2A, CMH7, TNNC1	ENSG00000129991	Troponin I3, cardiac type	P19429	19	55151767-55157773	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Muscle protein	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	622	heart muscle: 10813.5	Cell type enriched	Detected in many	11	Cardiomyocytes: 10855.1	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Heart muscle - Cardiomyocytes, Lung - Respiratory ciliated cells, Skeletal muscle - Skeletal myocytes, Testis - Late spermatids	Region enhanced	Detected in many		olfactory bulb: 10.9	Low region specificity	Detected in many			CAB009349, HPA046428	Enhanced		Approved	Vesicles,Cytosol					2400000		Cluster 44: Heart - Cardiac muscle contraction	Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling	Cluster 77: Cardiomyocytes - Muscle contraction	Cytosol	Vesicles	CAB009349: AB_793465, HPA046428: AB_2679661	unprognostic (2.12e-2)	unprognostic (3.05e-2)	unprognostic (2.44e-2)	unprognostic (1.36e-1)	unprognostic (2.08e-2)	unprognostic (2.81e-2)	unprognostic (1.37e-3)	unprognostic (2.13e-1)	unprognostic (9.62e-3)	unprognostic (9.40e-2)	unprognostic (3.34e-2)	unprognostic (2.17e-3)	unprognostic (4.02e-3)	unprognostic (8.89e-2)	unprognostic (8.54e-2)	unprognostic (1.05e-1)	unprognostic (9.82e-2)	Cardiomyocytes
PRRG3	TMG3	ENSG00000130032	Proline rich and Gla domain 3	Q9BZD7	X	151694607-151705924	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 11.4;epididymis: 7.4	Cell type enriched	Detected in some	24	Cardiomyocytes: 554.7	Cancer enhanced	Detected in some		stomach cancer: 1.3	Low region specificity	Detected in many			Low immune cell specificity	Detected in single			Low lineage specificity	Detected in single			Group enriched	Detected in some	4	testis cancer: 2.6;thyroid cancer: 1.5	Adipose subcutaneous - Adipose progenitor cells, Stomach - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA060566	Uncertain									Cluster 42: Non-specific - Transcription	Cluster 10: Brain - Neuronal signaling	Cluster 29: TT & NCI-H1385 - Synaptic signal transduction	Cluster 77: Cardiomyocytes - Muscle contraction			HPA060566: AB_2684321	unprognostic (1.85e-1)	unprognostic (1.21e-1)	unprognostic (7.71e-2)	unprognostic (1.77e-2)	unprognostic (4.42e-4)	unprognostic (7.24e-2)	unprognostic (2.29e-2)	unprognostic (1.28e-1)	unprognostic (2.06e-2)	unprognostic (5.11e-2)	unprognostic (3.01e-2)	unprognostic (2.26e-1)	unprognostic (1.98e-2)	unprognostic (7.69e-2)	unprognostic (4.64e-2)	unprognostic (1.57e-1)	unprognostic (1.84e-2)	Cardiomyocytes
FAM155B	CXorf63, TED, TMEM28	ENSG00000130054	Family with sequence similarity 155 member B	O75949	X	69504326-69532508	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	5	heart muscle: 43.5	Cell type enriched	Detected in some	5	Cardiomyocytes: 18.8	Cancer enhanced	Detected in many		thyroid cancer: 8.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Heart muscle - Cardiomyocytes, Prostate - Prostate glandular cells, Testis - Spermatogonia	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036093	Uncertain										Cluster 44: Heart - Cardiac muscle contraction	Cluster 7: Neuronal cell lines - Stereocilium	Cluster 77: Cardiomyocytes - Muscle contraction			HPA036093: AB_10673613	prognostic unfavorable (4.61e-5)	unprognostic (1.17e-1)	unprognostic (2.14e-1)	unprognostic (5.14e-3)	unprognostic (1.45e-1)	unprognostic (2.49e-2)	unprognostic (3.09e-4)	unprognostic (7.07e-2)	unprognostic (1.19e-2)	unprognostic (4.67e-2)	unprognostic (4.94e-3)	prognostic unfavorable (1.83e-4)	prognostic favorable (6.63e-4)	unprognostic (1.46e-2)	unprognostic (3.50e-2)	unprognostic (2.21e-1)	unprognostic (8.21e-2)	Cardiomyocytes
HRC	MGC133236	ENSG00000130528	Histidine rich calcium binding protein	P23327	19	49151198-49155396	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	50	heart muscle: 718.3;skeletal muscle: 453.0;tongue: 244.7	Cell type enriched	Detected in some	19	Cardiomyocytes: 2420.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	Myeloma: 6.3;Rhabdoid: 2.8;Sarcoma: 5.9	Heart muscle - Cardiomyocytes, Kidney - Fibroblasts, Liver - Hepatic stellate cells	Not detected	Not detected			Not detected	Not detected			HPA004833	Enhanced				Intracellular and membrane				100000		Cluster 38: Heart - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 77: Cardiomyocytes - Muscle contraction			HPA004833: AB_1079083	unprognostic (1.06e-1)	unprognostic (1.04e-3)	unprognostic (1.46e-2)	unprognostic (4.94e-2)	unprognostic (5.66e-2)	unprognostic (9.75e-3)	unprognostic (3.44e-1)	unprognostic (1.74e-1)	unprognostic (4.09e-1)	unprognostic (1.62e-1)	unprognostic (7.41e-3)	unprognostic (5.85e-3)	unprognostic (4.04e-2)	unprognostic (6.68e-2)	unprognostic (1.07e-1)	unprognostic (1.86e-1)	unprognostic (1.46e-1)	Cardiomyocytes
CKMT2	SMTCK	ENSG00000131730	Creatine kinase, mitochondrial 2	P17540	5	81233320-81266398	Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins		Kinase, Transferase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	49	heart muscle: 1240.1;skeletal muscle: 1430.8;tongue: 2324.4	Cell type enriched	Detected in many	7	Cardiomyocytes: 1007.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Immune cell enriched	Detected in single	7	NK-cell: 1.1	Lineage enriched	Detected in single	7	NK-cells: 1.1	Cancer enhanced	Detected in many		colorectal cancer: 7.7	Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes, Kidney - Intercalated cells, Prostate - Smooth muscle cells, Skin - Eccrine sweat gland cells, Stomach - Parietal cells	Not detected	Not detected			Low region specificity	Detected in many			HPA051880	Enhanced								3000000	Cluster 48: NK-cells - Unknown function	Cluster 38: Heart - Muscle contraction	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 77: Cardiomyocytes - Muscle contraction			HPA051880: AB_2681650	unprognostic (3.64e-3)	unprognostic (1.15e-1)	unprognostic (2.82e-3)	unprognostic (1.88e-2)	unprognostic (1.21e-2)	unprognostic (2.41e-2)	unprognostic (1.73e-2)	unprognostic (3.57e-2)	unprognostic (2.12e-1)	unprognostic (1.03e-1)	unprognostic (2.82e-1)	unprognostic (1.84e-1)	unprognostic (1.60e-2)	unprognostic (5.34e-2)	unprognostic (2.28e-1)	unprognostic (1.76e-1)	unprognostic (2.75e-3)	Cardiomyocytes
MYBPC3	CMH4, cMyBP-C, FHC	ENSG00000134571	Myosin binding protein C3	Q14896	11	47331406-47352702	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins	Cell adhesion	Actin-binding, Muscle protein	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	584	heart muscle: 1725.4	Cell type enriched	Detected in some	72	Cardiomyocytes: 2048.7	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes, Testis - Late spermatids	Region enriched	Detected in some	33	cerebellum: 34.4	Low region specificity	Detected in many			HPA040147, HPA043898	Enhanced								21000		Cluster 44: Heart - Cardiac muscle contraction	Cluster 66: Myeloid cells - Innate immune response	Cluster 77: Cardiomyocytes - Muscle contraction			HPA040147: AB_2676861, HPA043898: AB_2678720	unprognostic (1.06e-1)	unprognostic (1.47e-6)	unprognostic (2.17e-1)	unprognostic (6.16e-2)	unprognostic (3.00e-3)	unprognostic (1.40e-4)	unprognostic (7.47e-2)	unprognostic (2.72e-2)	unprognostic (2.53e-1)	unprognostic (1.62e-1)	unprognostic (9.53e-2)	unprognostic (4.22e-2)	unprognostic (1.11e-3)	unprognostic (2.11e-1)	unprognostic (1.96e-1)	unprognostic (4.15e-1)	unprognostic (3.21e-2)	Cardiomyocytes
CORIN	ATC2, CRN, Lrp4, PRSC, TMPRSS10	ENSG00000145244	Corin, serine peptidase	Q9Y5Q5	4	47593999-47838106	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	heart muscle: 56.9	Cell type enriched	Detected in some	6	Cardiomyocytes: 71.6	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Uterine cancer: 1.1	Heart muscle - Cardiomyocytes	Region enhanced	Detected in some		basal ganglia: 2.6	Low region specificity	Detected in some			HPA070941			Approved	Nuclear bodies,Plasma membrane,Actin filaments	Intracellular and membrane	Yes	No				Cluster 44: Heart - Cardiac muscle contraction	Cluster 20: Connective tissue cells - ECM organization	Cluster 77: Cardiomyocytes - Muscle contraction	Plasma membrane	Nuclear bodies, Actin filaments	HPA070941: AB_2686324	unprognostic (1.05e-1)	unprognostic (2.52e-1)	unprognostic (1.14e-1)	unprognostic (1.93e-1)	unprognostic (2.10e-1)	unprognostic (3.18e-1)	unprognostic (3.58e-4)	unprognostic (3.19e-1)	unprognostic (3.67e-2)	unprognostic (8.22e-2)	unprognostic (9.78e-2)	unprognostic (6.53e-2)	unprognostic (1.18e-1)	unprognostic (2.86e-2)	unprognostic (5.18e-2)	unprognostic (7.22e-2)	unprognostic (1.33e-2)	Cardiomyocytes
ITGB1BP2	CHORDC3	ENSG00000147166	Integrin subunit beta 1 binding protein 2	Q9UKP3	X	71301750-71305371	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 89.4;skeletal muscle: 46.1;tongue: 52.9	Cell type enriched	Detected in some	11	Cardiomyocytes: 112.3	Low cancer specificity	Detected in some			Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Colon - Smooth muscle cells, Heart muscle - Cardiomyocytes, Prostate - Smooth muscle cells	Not detected	Not detected			Not detected	Not detected			HPA040721			Approved	Cytosol						Cluster 45: Eosinophils - Innate immune response	Cluster 38: Heart - Muscle contraction	Cluster 52: Spermatids - Smell perception	Cluster 77: Cardiomyocytes - Muscle contraction	Cytosol		HPA040721: AB_10805827	unprognostic (1.87e-1)	unprognostic (2.65e-2)	unprognostic (6.91e-5)	unprognostic (1.95e-2)	unprognostic (7.92e-2)	unprognostic (1.54e-1)	unprognostic (3.81e-2)	unprognostic (9.02e-2)	unprognostic (4.69e-2)	unprognostic (2.15e-2)	unprognostic (4.85e-2)	unprognostic (3.17e-1)	unprognostic (3.08e-11)	unprognostic (4.38e-2)	unprognostic (3.63e-2)	unprognostic (2.99e-1)	unprognostic (2.64e-1)	Cardiomyocytes
ANKRD1	ALRP, C-193, CARP, CVARP, MCARP	ENSG00000148677	Ankyrin repeat domain 1	Q15327	10	90912096-90921087	Metabolic proteins, Predicted intracellular proteins			Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	heart muscle: 6540.8	Cell type enriched	Detected in some	10	Cardiomyocytes: 15967.1	Cancer enhanced	Detected in many		head and neck cancer: 7.5	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		testis cancer: 469.1		Not detected	Not detected			Not detected	Not detected			HPA038736	Enhanced		Approved	Nucleoplasm,Nucleoli fibrillar center			Yes				Cluster 44: Heart - Cardiac muscle contraction	Cluster 3: HUVEC & TIME - Signal transduction	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoli fibrillar center	Nucleoplasm	HPA038736: AB_2676184	unprognostic (2.45e-1)	unprognostic (6.14e-3)	unprognostic (2.24e-1)	unprognostic (4.39e-1)	unprognostic (9.14e-3)	prognostic unfavorable (1.95e-4)	unprognostic (1.28e-2)	unprognostic (6.63e-3)	unprognostic (2.19e-1)	unprognostic (3.27e-1)	unprognostic (4.51e-2)	unprognostic (3.40e-1)	unprognostic (2.72e-5)	unprognostic (3.40e-2)	unprognostic (2.79e-1)	unprognostic (7.22e-2)	unprognostic (3.16e-3)	Cardiomyocytes
SLC25A4	ANT1, PEO2, PEO3, T1	ENSG00000151729	Solute carrier family 25 member 4	P12235	4	185143266-185150382	Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters	Antiport, Host-virus interaction, Transport		Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	heart muscle: 245.1;skeletal muscle: 190.8;tongue: 346.6	Cell type enriched	Detected in all	6	Cardiomyocytes: 6458.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Adipose subcutaneous - Smooth muscle cells, Colon - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Alveolar cells type 2, Prostate - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Testis - Sertoli cells, Thyroid - Thyroid glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046835, HPA071684	Approved		Supported	Mitochondria					380000	Cluster 36: GdT-cells - Adaptive immune response	Cluster 38: Heart - Muscle contraction	Cluster 16: Skin cancer - Melanocyte processes	Cluster 77: Cardiomyocytes - Muscle contraction	Mitochondria		HPA046835: AB_2679831, HPA071684: AB_2686431	unprognostic (4.19e-2)	unprognostic (1.06e-2)	unprognostic (3.11e-1)	unprognostic (8.85e-2)	unprognostic (1.37e-1)	unprognostic (2.90e-3)	unprognostic (8.25e-2)	unprognostic (1.26e-2)	unprognostic (7.87e-2)	unprognostic (1.60e-1)	prognostic favorable (3.41e-4)	unprognostic (2.05e-1)	prognostic favorable (0.00e+0)	unprognostic (1.98e-1)	unprognostic (1.05e-1)	unprognostic (1.73e-1)	unprognostic (8.28e-3)	Cardiomyocytes
ATP5PF	ATP5, ATP5A, ATP5J, ATPM, CF6	ENSG00000154723	ATP synthase peripheral stalk subunit F6	P18859	21	25716503-25735673	Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Hydrogen ion transport, Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		tongue: 1595.8	Cell type enriched	Detected in all	5	Cardiomyocytes: 11406.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Prostate - Smooth muscle cells, Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031069	Supported		Supported	Mitochondria					820000	Cluster 12: Non-specific - Basic cellular processes	Cluster 39: Non-specific - Mitochondria	Cluster 45: Non-specific - Cell proliferation	Cluster 77: Cardiomyocytes - Muscle contraction	Mitochondria		HPA031069: AB_10603676	unprognostic (3.52e-2)	unprognostic (1.33e-1)	unprognostic (1.46e-1)	unprognostic (4.57e-2)	unprognostic (1.14e-1)	unprognostic (7.87e-2)	unprognostic (1.43e-1)	unprognostic (6.32e-2)	unprognostic (1.48e-1)	unprognostic (4.87e-2)	unprognostic (1.77e-1)	unprognostic (8.83e-2)	prognostic favorable (2.37e-5)	unprognostic (1.93e-1)	unprognostic (9.20e-2)	unprognostic (1.56e-1)	unprognostic (2.15e-2)	Cardiomyocytes
MYL3	CMH8, MLC1SB, MLC1V, VLC1	ENSG00000160808	Myosin light chain 3	P08590	3	46835111-46882172	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 9155.0;skeletal muscle: 5135.3;tongue: 2074.2	Cell type enriched	Detected in some	16	Cardiomyocytes: 4627.2	Group enriched	Detected in many	4	head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		liver cancer: 7.8	Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA016564, CAB018662, HPA046859, HPA063034	Enhanced		Approved	Nucleoli,Mitochondria					7300000	Cluster 29: Plasmacytoid DCs - Unknown function	Cluster 38: Heart - Muscle contraction	Cluster 6: BEWO - Unknown function	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoli, Mitochondria		CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927	unprognostic (3.11e-1)	unprognostic (2.64e-2)	unprognostic (5.55e-2)	unprognostic (1.51e-1)	unprognostic (1.77e-1)	unprognostic (4.44e-2)	unprognostic (9.67e-3)	unprognostic (3.37e-2)	unprognostic (4.72e-3)	unprognostic (3.63e-2)	unprognostic (1.08e-1)	unprognostic (7.88e-2)	prognostic favorable (1.22e-8)	unprognostic (1.16e-3)	unprognostic (9.45e-3)	unprognostic (7.18e-5)	unprognostic (2.53e-3)	Cardiomyocytes
COX7A1	COX7A, COX7AH	ENSG00000161281	Cytochrome c oxidase subunit 7A1	P24310	19	36150922-36152449	Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	18	heart muscle: 2260.5;skeletal muscle: 6947.0;tongue: 4960.0	Cell type enriched	Detected in many	25	Cardiomyocytes: 24900.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		thyroid cancer: 27.3	Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Prostate - Smooth muscle cells	Low region specificity	Detected in all			Low region specificity	Detected in all													Cluster 8: Neutrophils - Inflammatory response	Cluster 13: Striated muscle - Muscle contraction	Cluster 20: Connective tissue cells - ECM organization	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (5.48e-2)	unprognostic (1.19e-1)	unprognostic (6.13e-3)	unprognostic (6.46e-3)	unprognostic (5.33e-2)	unprognostic (3.87e-2)	unprognostic (3.77e-2)	unprognostic (9.93e-2)	unprognostic (1.92e-1)	unprognostic (1.41e-1)	unprognostic (9.49e-2)	unprognostic (1.46e-1)	unprognostic (7.84e-3)	unprognostic (7.27e-3)	unprognostic (9.44e-2)	unprognostic (6.23e-2)	unprognostic (1.54e-2)	Cardiomyocytes
NEXN	NELIN, nexilin	ENSG00000162614	Nexilin F-actin binding protein	Q0ZGT2	1	77888513-77943895	Disease related genes, Human disease related genes, Predicted intracellular proteins		Actin-binding	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	heart muscle: 404.8;skeletal muscle: 676.9;tongue: 548.9	Cell type enriched	Detected in many	5	Cardiomyocytes: 3575.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in many			Low cancer specificity	Detected in many			Colon - Smooth muscle cells, Liver - Hepatic stellate cells, Prostate - Smooth muscle cells	Region enhanced	Detected in all		basal ganglia: 40.4	Group enriched	Detected in all	4	basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2	HPA011185, HPA011904	Approved		Supported	Plasma membrane,Actin filaments					2900000	Cluster 8: Neutrophils - Inflammatory response	Cluster 13: Striated muscle - Muscle contraction	Cluster 20: Connective tissue cells - ECM organization	Cluster 77: Cardiomyocytes - Muscle contraction	Plasma membrane, Actin filaments		HPA011185: AB_1854409, HPA011904: 	unprognostic (9.73e-2)	unprognostic (6.72e-2)	prognostic unfavorable (5.60e-4)	unprognostic (1.72e-2)	unprognostic (1.11e-1)	unprognostic (1.42e-2)	unprognostic (1.62e-2)	unprognostic (1.09e-1)	unprognostic (3.03e-2)	unprognostic (2.22e-1)	unprognostic (1.46e-1)	unprognostic (3.25e-1)	unprognostic (5.41e-2)	unprognostic (5.60e-2)	unprognostic (2.48e-1)	unprognostic (9.65e-3)	unprognostic (3.68e-2)	Cardiomyocytes
SLMAP	KIAA1601, SLAP	ENSG00000163681	Sarcolemma associated protein	Q14BN4	3	57755450-57930003	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Cardiomyocytes: 482.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Adipose subcutaneous - Smooth muscle cells, Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Testis - Spermatocytes, Testis - Spermatogonia	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002357, HPA002358	Enhanced		Approved	Endoplasmic reticulum					9200	Cluster 49: Eosinophils - Unknown function	Cluster 12: Smooth muscle tissue - Mixed function	Cluster 5: Non-specific - Unknown function	Cluster 15: Smooth muscle cells - Muscle contraction	Endoplasmic reticulum		HPA002357: AB_1080023, HPA002358: AB_1080021	unprognostic (3.70e-1)	unprognostic (2.87e-2)	unprognostic (1.82e-3)	unprognostic (3.43e-2)	unprognostic (3.34e-1)	unprognostic (6.18e-2)	unprognostic (1.47e-2)	prognostic unfavorable (7.98e-4)	unprognostic (1.23e-1)	unprognostic (1.59e-1)	unprognostic (2.59e-3)	unprognostic (1.06e-1)	prognostic favorable (1.58e-6)	unprognostic (8.18e-2)	unprognostic (1.93e-1)	unprognostic (1.92e-2)	unprognostic (6.08e-2)	Cardiomyocytes
FBXO40	Fbx40, KIAA1195	ENSG00000163833	F-box protein 40	Q9UH90	3	121593379-121630295	Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in some	97	heart muscle: 90.4;skeletal muscle: 162.2;tongue: 100.3	Cell type enriched	Detected in some	20	Cardiomyocytes: 517.3	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes	Region enhanced	Detected in some		pons and medulla: 1.7	Low region specificity	Detected in many													Cluster 49: Eosinophils - Unknown function	Cluster 13: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (1.67e-2)	unprognostic (1.23e-4)			unprognostic (9.17e-2)	unprognostic (6.65e-2)	unprognostic (2.62e-1)	unprognostic (1.43e-2)	unprognostic (1.22e-1)	unprognostic (7.01e-2)	unprognostic (2.91e-1)	unprognostic (2.50e-1)	unprognostic (3.48e-2)	unprognostic (1.01e-1)	unprognostic (4.14e-1)		unprognostic (4.30e-2)	Cardiomyocytes
SYNPO2L	FLJ12921	ENSG00000166317	Synaptopodin 2 like	Q9H987	10	73644881-73663803	Plasma proteins, Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	18	heart muscle: 262.3;skeletal muscle: 279.2;tongue: 87.2	Cell type enriched	Detected in some	4	Cardiomyocytes: 755.0	Group enriched	Detected in some	6	breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Sarcoma: 2.8	Heart muscle - Cardiomyocytes, Lung - Fibroblast_1, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA055192, HPA057142	Enhanced									Cluster 17: Basophils - Unknown function	Cluster 38: Heart - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 77: Cardiomyocytes - Muscle contraction			HPA055192: AB_2682732, HPA057142: AB_2683348	unprognostic (2.75e-1)	unprognostic (1.58e-1)	unprognostic (1.20e-3)	unprognostic (3.65e-3)	unprognostic (1.27e-1)	unprognostic (1.05e-1)	unprognostic (1.33e-1)	unprognostic (4.54e-2)	unprognostic (3.30e-1)	unprognostic (2.49e-2)	unprognostic (4.50e-2)	unprognostic (2.32e-1)	unprognostic (7.44e-4)	unprognostic (1.09e-1)	unprognostic (1.01e-1)	unprognostic (1.72e-2)	unprognostic (1.34e-1)	Cardiomyocytes
RBPMS2		ENSG00000166831	RNA binding protein, mRNA processing factor 2	Q6ZRY4	15	64739891-64775589	Predicted intracellular proteins		Developmental protein, RNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 300.8;intestine: 147.2	Cell type enriched	Detected in many	4	Cardiomyocytes: 189.4	Cancer enriched	Detected in all	4	testis cancer: 37.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in many	4	Rhabdoid: 24.8;testis cancer: 86.5	Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Smooth muscle cells, Testis - Spermatogonia	Low region specificity	Detected in all			Low region specificity	Detected in all													Cluster 21: B-cells - Adaptive immune response	Cluster 46: Fibroblasts - ECM organization	Cluster 34: Rabdoid cancer - Embryonic development	Cluster 72: Smooth muscle cells - ECM organization				unprognostic (1.68e-1)	unprognostic (2.29e-1)	unprognostic (1.07e-2)	unprognostic (6.79e-2)	unprognostic (1.08e-1)	unprognostic (1.51e-1)	unprognostic (1.61e-1)	unprognostic (4.51e-2)	unprognostic (6.41e-2)	unprognostic (5.86e-2)	unprognostic (2.21e-2)	unprognostic (4.47e-2)	prognostic favorable (1.48e-4)	unprognostic (2.05e-2)	unprognostic (1.12e-1)	unprognostic (1.23e-1)	unprognostic (4.68e-3)	Cardiomyocytes
MYOZ2	C4orf5, CS-1, FATZ-2	ENSG00000172399	Myozenin 2	Q9NPC6	4	119135832-119187789	Disease related genes, Predicted intracellular proteins			Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 771.4;skeletal muscle: 225.5;tongue: 173.4	Cell type enriched	Detected in some	39	Cardiomyocytes: 3128.7	Cancer enhanced	Detected in some		head and neck cancer: 1.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	Rhabdoid: 1.2;Sarcoma: 3.4;skin cancer: 3.6;testis cancer: 1.0	Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Smooth muscle cells, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in single			HPA035763, HPA035764	Enhanced		Approved	Nucleoplasm,Cytosol							Cluster 38: Heart - Muscle contraction	Cluster 33: Skin cancer - Membrane components	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoplasm, Cytosol		HPA035763: AB_2674770, HPA035764: AB_10696509	unprognostic (2.53e-1)	unprognostic (9.20e-2)	unprognostic (6.94e-2)	unprognostic (2.14e-1)	unprognostic (2.57e-1)	unprognostic (2.34e-2)	unprognostic (5.71e-1)	unprognostic (2.18e-1)	unprognostic (4.77e-2)	unprognostic (4.04e-1)	unprognostic (8.25e-2)	unprognostic (5.07e-2)	unprognostic (6.19e-7)	unprognostic (6.66e-4)	unprognostic (2.43e-1)	unprognostic (3.06e-1)	unprognostic (2.83e-2)	Cardiomyocytes
NPPA	ANP, PND	ENSG00000175206	Natriuretic peptide A	P01160	1	11845709-11848345	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Hormone, Vasoactive, Vasodilator	Atrial fibrillation, Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	873	heart muscle: 60060.6	Cell type enriched	Detected in some	41	Cardiomyocytes: 18703.1	Cancer enriched	Detected in some	9	glioma: 7.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	4	lung cancer: 7.4		Region enriched	Detected in some	7	olfactory bulb: 22.8	Low region specificity	Detected in all			HPA058269, HPA064007	Enhanced				Secreted to blood				1200000		Cluster 44: Heart - Cardiac muscle contraction	Cluster 41: Non-specific - Cilium assembly	Cluster 77: Cardiomyocytes - Muscle contraction			HPA058269: AB_2683660, HPA064007: 	unprognostic (1.27e-3)	unprognostic (3.12e-2)	unprognostic (2.15e-1)	unprognostic (1.30e-1)	unprognostic (1.94e-1)	unprognostic (1.95e-1)	unprognostic (2.02e-1)	unprognostic (2.01e-1)	unprognostic (1.48e-1)	unprognostic (3.25e-2)	unprognostic (9.72e-3)	unprognostic (2.21e-1)	unprognostic (5.93e-4)	unprognostic (2.31e-1)	unprognostic (1.59e-1)	unprognostic (1.20e-1)	unprognostic (6.70e-2)	Cardiomyocytes
NKX2-5	CSX, CSX1, NKX2.5, NKX2E, NKX4-1	ENSG00000183072	NK2 homeobox 5	P52952	5	173232109-173235311	Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding	Atrial septal defect, Congenital hypothyroidism, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	heart muscle: 229.0	Cell type enriched	Detected in some	23	Cardiomyocytes: 36.3	Cancer enhanced	Detected in many		glioma: 3.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Sarcoma: 20.1	Heart muscle - Cardiomyocytes	Not detected	Not detected			Not detected	Not detected			HPA065034			Approved	Nucleoplasm,Cytosol							Cluster 44: Heart - Cardiac muscle contraction	Cluster 27: TE 441.T - Unknown function	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoplasm	Cytosol	HPA065034: AB_2685409	unprognostic (3.81e-1)	unprognostic (8.53e-2)		unprognostic (2.62e-2)	unprognostic (9.57e-3)	unprognostic (3.22e-3)		unprognostic (6.63e-2)	unprognostic (1.57e-1)	unprognostic (2.72e-1)	unprognostic (2.31e-1)			unprognostic (5.80e-2)	unprognostic (2.19e-1)		unprognostic (1.77e-2)	Cardiomyocytes
NDUFA12	B17.2, DAP13	ENSG00000184752	NADH:ubiquinone oxidoreductase subunit A12	Q9UI09	12	94897055-95003748	Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins	Electron transport, Respiratory chain, Transport		Disease variant, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 558.6;tongue: 563.1	Cell type enriched	Detected in all	4	Cardiomyocytes: 2532.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Testis - Early spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039903	Supported		Supported	Mitochondria,Cytosol						Cluster 12: Non-specific - Basic cellular processes	Cluster 39: Non-specific - Mitochondria	Cluster 45: Non-specific - Cell proliferation	Cluster 77: Cardiomyocytes - Muscle contraction	Mitochondria	Cytosol	HPA039903: AB_10795516	unprognostic (2.76e-1)	unprognostic (5.32e-3)	unprognostic (1.17e-1)	unprognostic (2.56e-2)	unprognostic (2.85e-1)	unprognostic (4.03e-2)	unprognostic (3.05e-2)	unprognostic (6.68e-2)	unprognostic (1.67e-1)	unprognostic (2.47e-2)	unprognostic (1.89e-1)	unprognostic (1.64e-1)	unprognostic (3.13e-3)	unprognostic (2.32e-1)	unprognostic (1.65e-1)	unprognostic (6.13e-2)	unprognostic (3.27e-2)	Cardiomyocytes
SBK2	SGK069	ENSG00000187550	SH3 domain binding kinase family member 2	P0C263	19	55528611-55537133	Enzymes, Predicted membrane proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Group enriched	Detected in some	28	heart muscle: 87.2;tongue: 28.8	Cell type enriched	Detected in some	4	Cardiomyocytes: 23.3	Cancer enhanced	Detected in some		ovarian cancer: 1.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Sarcoma: 11.4	Adipose visceral - Mesothelial cells, Heart muscle - Cardiomyocytes, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA030631	Enhanced									Cluster 1: Neutrophils - Mixed function	Cluster 38: Heart - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 77: Cardiomyocytes - Muscle contraction			HPA030631: AB_10602088	unprognostic (1.33e-1)			unprognostic (1.85e-3)	unprognostic (4.57e-1)	unprognostic (3.49e-1)				unprognostic (5.43e-3)	unprognostic (4.18e-3)		unprognostic (2.08e-1)	unprognostic (6.58e-2)	unprognostic (1.05e-1)			Cardiomyocytes
FITM2	C20orf142, dJ881L22.2, FIT2	ENSG00000197296	Fat storage inducing transmembrane protein 2	Q8N6M3	20	44302840-44311202	Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters	Lipid metabolism	Hydrolase	Deafness, Disease variant, Dystonia, Intellectual disability	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	heart muscle: 67.4	Cell type enriched	Detected in many	10	Cardiomyocytes: 161.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Skin - Sebaceous gland cells, Testis - Sertoli cells	Low region specificity	Detected in all			Low region specificity	Detected in all													Cluster 32: T-cells - Unknown function	Cluster 44: Heart - Cardiac muscle contraction	Cluster 37: Ovarian cancer RMG-I - Cellular stress response	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (2.92e-2)	unprognostic (7.61e-2)	unprognostic (2.27e-2)	unprognostic (2.10e-3)	unprognostic (1.02e-1)	unprognostic (3.57e-3)	unprognostic (1.63e-2)	unprognostic (3.90e-2)	unprognostic (8.43e-2)	unprognostic (5.19e-2)	unprognostic (6.56e-3)	unprognostic (1.19e-1)	prognostic favorable (8.98e-12)	unprognostic (2.07e-1)	unprognostic (2.54e-1)	unprognostic (3.38e-3)	unprognostic (2.49e-3)	Cardiomyocytes
MYH6		ENSG00000197616	Myosin heavy chain 6	P13533	14	23381982-23408273	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Atrial septal defect, Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	54	heart muscle: 2882.7	Cell type enriched	Detected in some	46	Cardiomyocytes: 6689.4	Cancer enriched	Detected in single	5	testis cancer: 1.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected			Low region specificity	Detected in many			HPA001239, HPA001349, CAB075723, CAB075724, CAB075725	Enhanced		Uncertain	Focal adhesion sites					25000000		Cluster 44: Heart - Cardiac muscle contraction	Cluster 47: Retina - Visual perception	Cluster 77: Cardiomyocytes - Muscle contraction	Focal adhesion sites		CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437	unprognostic (2.09e-2)	unprognostic (8.53e-4)		unprognostic (1.80e-2)	unprognostic (2.99e-1)	unprognostic (1.66e-1)		unprognostic (2.09e-1)	unprognostic (1.66e-1)	unprognostic (5.73e-2)	unprognostic (1.44e-2)	unprognostic (5.34e-3)		unprognostic (6.90e-2)	unprognostic (1.42e-1)	unprognostic (1.85e-1)	unprognostic (1.22e-2)	Cardiomyocytes
MYL4	ALC1, AMLC, GT1, PRO1957	ENSG00000198336	Myosin light chain 4	P12829	17	47200446-47223679	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Atrial fibrillation, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	47	heart muscle: 6347.0	Cell type enriched	Detected in many	4	Cardiomyocytes: 2143.5	Cancer enriched	Detected in some	5	thyroid cancer: 11.7	Not detected	Not detected			Immune cell enriched	Detected in single	9	plasmacytoid DC: 1.8	Lineage enriched	Detected in single	9	dendritic cells: 1.8	Group enriched	Detected in some	22	Leukemia: 69.9;Sarcoma: 44.2;testis cancer: 24.3	Heart muscle - Cardiomyocytes	Group enriched	Detected in all	6	amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9	Not detected	Not detected			HPA046859, HPA051884, HPA063034	Enhanced		Approved	Plasma membrane					3100000	Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 44: Heart - Cardiac muscle contraction	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 77: Cardiomyocytes - Muscle contraction	Plasma membrane		HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927	unprognostic (2.43e-2)	unprognostic (9.57e-2)	unprognostic (2.25e-1)	unprognostic (5.51e-2)	unprognostic (2.33e-1)	unprognostic (4.12e-3)	unprognostic (5.06e-3)	unprognostic (1.34e-1)	unprognostic (1.13e-1)	unprognostic (6.52e-2)	unprognostic (2.10e-2)	unprognostic (7.37e-2)	unprognostic (1.00e-6)	unprognostic (1.92e-4)	unprognostic (2.54e-1)	unprognostic (6.51e-3)	unprognostic (1.50e-1)	Cardiomyocytes
PLN	CMD1P, PLB	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters			Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	heart muscle: 1563.4;skeletal muscle: 507.3	Cell type enriched	Detected in some	15	Cardiomyocytes: 4191.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	5	skin cancer: 4.4	Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Colon - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Thyroid - Smooth muscle cells	Low region specificity	Detected in many							CAB005597, HPA026900	Enhanced										Cluster 38: Heart - Muscle contraction	Cluster 33: Skin cancer - Membrane components	Cluster 77: Cardiomyocytes - Muscle contraction			CAB005597: AB_2252716, HPA026900: AB_1855314	unprognostic (2.49e-1)	unprognostic (5.67e-2)	unprognostic (1.96e-3)	unprognostic (4.81e-2)	unprognostic (1.20e-1)	unprognostic (5.54e-2)	unprognostic (2.35e-3)	unprognostic (4.66e-2)	unprognostic (3.97e-1)	unprognostic (8.98e-2)	unprognostic (8.98e-2)	unprognostic (3.28e-1)	prognostic unfavorable (4.11e-4)	unprognostic (2.98e-3)	unprognostic (1.80e-1)	unprognostic (2.11e-1)	prognostic unfavorable (5.59e-4)	Cardiomyocytes
MT-ND6	MTND6, NAD6, ND6	ENSG00000198695	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	P03923	MT	14149-14673	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Disease variant, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 35802.7;skeletal muscle: 57879.2	Cell type enriched	Detected in many	9	Cardiomyocytes: 12019.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Lung - Alveolar cells type 2	Low region specificity	Detected in all			Low region specificity	Detected in all													Cluster 41: Basophils - Cellular respiration	Cluster 39: Non-specific - Mitochondria	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (1.96e-1)	unprognostic (3.27e-1)	unprognostic (2.28e-1)	unprognostic (1.13e-1)	unprognostic (2.21e-1)	unprognostic (1.22e-2)	unprognostic (1.03e-3)	unprognostic (6.02e-3)	unprognostic (1.68e-2)	unprognostic (1.48e-1)	unprognostic (6.06e-3)	unprognostic (2.91e-1)	prognostic favorable (8.91e-6)	unprognostic (3.64e-2)	unprognostic (1.42e-2)	unprognostic (1.15e-2)	unprognostic (2.92e-2)	Cardiomyocytes
MT-ND5	MTND5, NAD5, ND5	ENSG00000198786	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	P03915	MT	12337-14148	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 25147.7;heart muscle: 26116.9;skeletal muscle: 25697.4	Cell type enriched	Detected in all	4	Cardiomyocytes: 32207.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Breast - Adipocytes (Breast), Lung - Alveolar cells type 2	Low region specificity	Detected in all			Low region specificity	Detected in all													Cluster 41: Basophils - Cellular respiration	Cluster 39: Non-specific - Mitochondria	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (2.87e-1)	unprognostic (3.18e-2)	unprognostic (3.00e-1)	unprognostic (1.53e-1)	unprognostic (2.99e-1)	unprognostic (1.30e-1)	unprognostic (1.07e-3)	unprognostic (5.09e-3)	unprognostic (1.06e-2)	unprognostic (3.01e-1)	unprognostic (3.29e-3)	unprognostic (4.78e-2)	prognostic favorable (7.31e-5)	unprognostic (9.93e-3)	unprognostic (8.75e-2)	unprognostic (1.26e-2)	unprognostic (3.68e-2)	Cardiomyocytes
LRRC10	HRLRRP, LRRC10A	ENSG00000198812	Leucine rich repeat containing 10	Q5BKY1	12	69608564-69610907	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in single	55	heart muscle: 40.0	Cell type enriched	Detected in some	43	Cardiomyocytes: 47.7	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes	Not detected	Not detected			Not detected	Not detected														Cluster 44: Heart - Cardiac muscle contraction	Cluster 40: Non-specific - Enzymes	Cluster 77: Cardiomyocytes - Muscle contraction								unprognostic (3.76e-4)										unprognostic (4.59e-1)			Cardiomyocytes
METTL11B	C1orf184, HOMT1B	ENSG00000203740	Methyltransferase like 11B	Q5VVY1	1	170145959-170168866	Enzymes, Predicted intracellular proteins		Methyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	heart muscle: 1.7;skeletal muscle: 1.0	Cell type enriched	Detected in some	8	Cardiomyocytes: 8.5	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA028049	Uncertain										Cluster 38: Heart - Muscle contraction	Cluster 29: TT & NCI-H1385 - Synaptic signal transduction	Cluster 77: Cardiomyocytes - Muscle contraction			HPA028049: AB_10610139	unprognostic (1.12e-1)	unprognostic (2.57e-1)	unprognostic (5.62e-2)		unprognostic (7.59e-2)	unprognostic (7.25e-2)		unprognostic (1.19e-1)	unprognostic (8.68e-2)	unprognostic (5.24e-2)	unprognostic (2.76e-3)			unprognostic (5.43e-2)	unprognostic (4.56e-1)		unprognostic (5.79e-4)	Cardiomyocytes
RBM20		ENSG00000203867	RNA binding motif protein 20	Q5T481	10	110644336-110839468	Disease related genes, Human disease related genes, Predicted intracellular proteins	mRNA processing, mRNA splicing	RNA-binding	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 40.8;pancreas: 20.2	Cell type enriched	Detected in some	10	Cardiomyocytes: 183.4	Low cancer specificity	Detected in some			Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Neuroblastoma: 10.6	Heart muscle - Cardiomyocytes, Lung - Respiratory ciliated cells	Low region specificity	Detected in single							HPA035806, HPA070358	Approved		Approved	Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge		Yes	No				Cluster 38: Heart - Muscle contraction	Cluster 21: Neuroblastoma - Neuronal signaling	Cluster 77: Cardiomyocytes - Muscle contraction	Nucleoplasm, Golgi apparatus	Nucleoli, Cytokinetic bridge	HPA035806: AB_10672097, HPA070358: 	unprognostic (2.43e-1)	unprognostic (8.24e-3)	unprognostic (5.81e-2)	unprognostic (1.27e-2)	unprognostic (1.03e-1)	unprognostic (2.03e-2)	unprognostic (2.75e-2)	unprognostic (5.47e-3)	unprognostic (1.33e-1)	unprognostic (2.78e-2)	unprognostic (4.14e-3)	unprognostic (1.44e-1)	unprognostic (2.39e-3)	unprognostic (3.34e-1)	unprognostic (3.35e-2)	unprognostic (1.20e-1)	unprognostic (6.46e-2)	Cardiomyocytes
TECRL	DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL	ENSG00000205678	Trans-2,3-enoyl-CoA reductase like	Q5HYJ1	4	64275257-64409468	Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins		Oxidoreductase	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	10	heart muscle: 554.3	Cell type enriched	Detected in some	67	Cardiomyocytes: 2536.7	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	98	Rhabdoid: 50.5	Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Not detected	Not detected														Cluster 44: Heart - Cardiac muscle contraction	Cluster 34: Rabdoid cancer - Embryonic development	Cluster 77: Cardiomyocytes - Muscle contraction																					Cardiomyocytes
MT-ND4L	MTND4L, NAD4L, ND4L	ENSG00000212907	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	P03901	MT	10470-10766	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 132930.7;heart muscle: 145078.7	Cell type enriched	Detected in all	5	Cardiomyocytes: 27304.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA075648			Approved	Centrosome,Mitochondria,Cytosol						Cluster 41: Basophils - Cellular respiration	Cluster 39: Non-specific - Mitochondria	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 77: Cardiomyocytes - Muscle contraction	Mitochondria	Centrosome, Cytosol	HPA075648: AB_2686760	unprognostic (5.81e-2)	unprognostic (3.46e-2)	unprognostic (2.76e-2)	unprognostic (7.91e-2)	unprognostic (5.64e-2)	unprognostic (1.05e-1)	prognostic favorable (4.47e-4)	unprognostic (1.97e-1)	unprognostic (4.04e-2)	unprognostic (4.63e-3)	unprognostic (6.61e-2)	unprognostic (7.38e-3)	unprognostic (1.39e-1)	unprognostic (3.09e-1)	unprognostic (3.73e-1)	unprognostic (2.97e-2)	unprognostic (5.68e-2)	Cardiomyocytes
LINGO4	LRRN6D	ENSG00000213171	Leucine rich repeat and Ig domain containing 4	Q6UY18	1	151800264-151805419	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Tissue enhanced	Detected in some		skeletal muscle: 21.3;tongue: 5.6	Cell type enriched	Detected in single	4	Cardiomyocytes: 1.3	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes	Group enriched	Detected in many	4	cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4	Region enriched	Detected in many	7	spinal cord: 19.7	HPA060781	Uncertain		Uncertain	Golgi apparatus,Vesicles							Cluster 80: Striated muscle - Unknown function	Cluster 54: Lymphoma - Cytokine signaling	Cluster 77: Cardiomyocytes - Muscle contraction	Golgi apparatus, Vesicles		HPA060781: AB_2684361	unprognostic (2.71e-2)	unprognostic (1.98e-1)	unprognostic (1.33e-3)	unprognostic (1.96e-1)	unprognostic (8.65e-2)	unprognostic (3.16e-2)	unprognostic (1.49e-5)	unprognostic (1.14e-1)	unprognostic (2.04e-1)	unprognostic (2.39e-1)	unprognostic (1.94e-4)	unprognostic (6.92e-2)	unprognostic (3.94e-4)	unprognostic (3.84e-1)	unprognostic (1.65e-1)	unprognostic (7.06e-2)	unprognostic (5.60e-2)	Cardiomyocytes
SMCO1	C3orf43, DKFZp313B0440, FLJ41923	ENSG00000214097	Single-pass membrane protein with coiled-coil domains 1	Q147U7	3	196506879-196515346	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	41	heart muscle: 41.5;skeletal muscle: 149.2;tongue: 107.0	Cell type enriched	Detected in some	4	Cardiomyocytes: 120.4	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA061937			Approved	Endoplasmic reticulum,Golgi apparatus						Cluster 40: NK-cells - Unknown function	Cluster 13: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 77: Cardiomyocytes - Muscle contraction	Golgi apparatus	Endoplasmic reticulum	HPA061937: AB_2684642	unprognostic (4.86e-2)	unprognostic (1.62e-1)		unprognostic (1.51e-2)	unprognostic (6.08e-2)	unprognostic (1.72e-2)		unprognostic (1.73e-1)		unprognostic (3.25e-1)	unprognostic (1.64e-1)	unprognostic (1.94e-2)		unprognostic (2.95e-1)	unprognostic (2.72e-1)	unprognostic (3.07e-2)	unprognostic (2.88e-3)	Cardiomyocytes
MYBPHL		ENSG00000221986	Myosin binding protein H like	A2RUH7	1	109292365-109307011	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	35	heart muscle: 105.8	Cell type enriched	Detected in some	5	Cardiomyocytes: 136.2	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	10	Sarcoma: 4.8		Not detected	Not detected			Low region specificity	Detected in many			HPA077633			Approved	Vesicles							Cluster 44: Heart - Cardiac muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 77: Cardiomyocytes - Muscle contraction	Vesicles		HPA077633: 	unprognostic (6.07e-3)	unprognostic (1.43e-1)	unprognostic (2.78e-1)	unprognostic (1.17e-2)	unprognostic (1.47e-1)	unprognostic (1.37e-1)	unprognostic (1.80e-2)	unprognostic (1.24e-2)	unprognostic (5.53e-2)	unprognostic (5.89e-1)	unprognostic (5.22e-3)	unprognostic (4.10e-1)	unprognostic (7.05e-9)	unprognostic (6.01e-2)	unprognostic (1.53e-1)	unprognostic (5.81e-2)	unprognostic (2.64e-1)	Cardiomyocytes
MTRNR2L8		ENSG00000255823	MT-RNR2 like 8	P0CJ75	11	10507894-10509186	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Tissue enhanced	Detected in many		brain: 20406.5;choroid plexus: 8122.9;skeletal muscle: 7550.7	Cell type enriched	Detected in some	37	Cardiomyocytes: 348.2	Cancer enhanced	Detected in many		stomach cancer: 6.7	Low region specificity	Detected in all			Group enriched	Detected in all	4	basophil: 3689.6;eosinophil: 2784.3;neutrophil: 9219.1	Lineage enriched	Detected in all	7	granulocytes: 9219.1	Low cancer specificity	Detected in all																	Secreted to blood					Cluster 1: Neutrophils - Mixed function	Cluster 32: Brain & Lymphoid tissue - Unknown function	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (6.19e-2)	unprognostic (1.43e-1)	unprognostic (6.66e-2)	unprognostic (3.26e-2)	unprognostic (3.71e-2)	unprognostic (3.52e-2)	unprognostic (2.81e-2)	unprognostic (3.45e-2)	unprognostic (5.28e-2)	unprognostic (1.41e-1)	unprognostic (4.87e-2)	unprognostic (1.90e-1)	unprognostic (4.59e-2)	unprognostic (4.59e-2)	unprognostic (3.45e-2)	unprognostic (1.12e-1)	unprognostic (1.96e-2)	Cardiomyocytes
MTRNR2L1		ENSG00000256618	MT-RNR2 like 1	P0CJ68	17	22523415-22524663	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Tissue enhanced	Detected in many		brain: 20164.8;choroid plexus: 8845.1	Cell type enriched	Detected in many	38	Cardiomyocytes: 2885.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in all		neutrophil: 4804.8	Lineage enriched	Detected in all	7	granulocytes: 4804.8	Low cancer specificity	Detected in all																	Secreted to blood					Cluster 1: Neutrophils - Mixed function	Cluster 32: Brain & Lymphoid tissue - Unknown function	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (2.31e-2)	unprognostic (1.50e-1)	unprognostic (1.08e-1)	unprognostic (4.41e-3)	unprognostic (2.99e-2)	unprognostic (9.82e-3)	prognostic favorable (8.99e-4)	unprognostic (2.14e-1)	unprognostic (2.59e-2)	unprognostic (1.48e-2)	unprognostic (2.42e-2)	unprognostic (1.63e-2)	unprognostic (2.56e-2)	unprognostic (3.35e-2)	unprognostic (1.64e-1)	unprognostic (1.49e-2)	unprognostic (5.21e-3)	Cardiomyocytes
MYZAP	GCOM1, Gup, Gup1, MYOZAP	ENSG00000263155	Myocardial zonula adherens protein	P0CAP1	15	57591904-57685364	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	heart muscle: 588.9	Cell type enriched	Detected in many	8	Cardiomyocytes: 543.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Immune cell enhanced	Detected in some		naive B-cell: 3.4;naive CD4 T-cell: 2.0	Low lineage specificity	Detected in many			Cancer enhanced	Detected in many		Bile duct cancer: 14.9	Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Prostate - Smooth muscle cells, Thyroid - Fibroblasts									HPA039827	Approved									Cluster 21: B-cells - Adaptive immune response	Cluster 44: Heart - Cardiac muscle contraction	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 77: Cardiomyocytes - Muscle contraction			HPA039827: AB_10673364	unprognostic (1.30e-2)	unprognostic (1.25e-1)	unprognostic (2.44e-1)	unprognostic (1.66e-1)	unprognostic (9.26e-3)	unprognostic (1.49e-1)	unprognostic (6.10e-3)	unprognostic (5.19e-2)	unprognostic (8.92e-2)	unprognostic (2.30e-2)	unprognostic (1.26e-1)	unprognostic (9.67e-2)	unprognostic (1.44e-1)	unprognostic (1.12e-1)	unprognostic (1.07e-1)	unprognostic (3.86e-2)	unprognostic (1.77e-2)	Cardiomyocytes
MTRNR2L12		ENSG00000269028	MT-RNR2 like 12	P0DMP1	3	96617188-96618236	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level	Tissue enhanced	Detected in many		brain: 125442.5;choroid plexus: 60537.0	Cell type enriched	Detected in some	18	Cardiomyocytes: 447.5	Cancer enhanced	Detected in all		stomach cancer: 14.6	Low region specificity	Detected in all			Immune cell enhanced	Detected in all		neutrophil: 23357.3	Lineage enriched	Detected in all	7	granulocytes: 23357.3	Low cancer specificity	Detected in all																	Secreted to blood					Cluster 1: Neutrophils - Mixed function	Cluster 32: Brain & Lymphoid tissue - Unknown function	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 77: Cardiomyocytes - Muscle contraction				unprognostic (3.79e-2)	unprognostic (1.05e-1)	unprognostic (1.88e-2)	unprognostic (1.37e-1)	unprognostic (1.09e-1)	unprognostic (9.76e-3)	unprognostic (1.69e-3)	unprognostic (1.81e-2)	unprognostic (7.77e-2)	unprognostic (3.55e-2)	unprognostic (2.08e-2)	unprognostic (4.90e-2)	unprognostic (9.59e-3)	unprognostic (1.81e-2)	unprognostic (2.61e-1)	unprognostic (2.08e-1)	unprognostic (1.85e-2)	Cardiomyocytes
SNURF		ENSG00000273173	SNRPN upstream reading frame	Q9Y675	15	24954986-24977850	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 62.9	Cell type enriched	Detected in many	4	Cardiomyocytes: 40.1	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all												HPA065733			Supported	Nuclear speckles						Cluster 35: T-regs - Unknown function	Cluster 54: Non-specific - Microtubule organization	Cluster 45: Non-specific - Cell proliferation	Cluster 77: Cardiomyocytes - Muscle contraction	Nuclear speckles		HPA065733: AB_2685548	unprognostic (2.08e-1)	unprognostic (2.88e-2)	unprognostic (6.82e-2)	unprognostic (4.59e-3)	unprognostic (4.03e-2)	unprognostic (1.40e-3)	unprognostic (4.39e-2)	unprognostic (6.89e-3)	unprognostic (1.56e-2)	unprognostic (6.74e-2)	unprognostic (8.91e-4)	unprognostic (3.77e-1)	unprognostic (1.77e-2)	unprognostic (6.04e-2)	unprognostic (1.06e-1)	unprognostic (1.45e-1)	unprognostic (1.12e-2)	Cardiomyocytes
